. What’s next?
On 30 November, after a series of six clinical studies, including two phase 3 studies, the FDA approved Rebyota from Ferring Pharmaceuticals for the treatment of recurrent infections of where traditional antibiotics are not effective. Rebyota is taken from stool of uninfected individuals. Healthy donors are screened for pathogens and their fecal matter is rectally transferred to a patient’s gut, where the microbial community is re-established.
ferring finch_tx VedantaBio ResearchViome FederationBio BankBiome Next step is obvious;
ferring finch_tx VedantaBio ResearchViome FederationBio BankBiome Tailored probiotics for the individual
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: